Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Primary Index

View All
Blastomycosis Deep Endemic Mycoses Endemic Mycoses - Related Resources
Bleeding, vaginal
Bleeding angiodysplasia
Bleeding complication
Bleeding diathesis
Bleeding irregularities
Bleeding peptic ulcer
Bleeding-related mortality
Bleeding
Bleomycin Adverse Effects of Antineoplastic Agents Chemical Pleurodesis for Malignant Pleural Effusions Interventions for Treating Oral Leukoplakia Local Treatments for Cutaneous Warts Long-Term Adverse Effects of Antineoplastic Agents Neoadjuvant Chemoradiation for Advanced Primary Vulvar Cancer Problems of Childhood or Adolescence Cancer Survivors in Adulthood Treatment of Severe or Progressive Kaposi's Sarcoma (Ks) in HIV-1 Infected Adults Use of Chemical Pleurodesis for Treatment of Malignant Pleural Effusions
Blepharitis
Blepharoptosis Peripheral Facial Paralysis Ptosis
Blepharoptosis, congenital
Blepharospasm Adverse effects Adverse Effects Botulinum Toxin Type A for Blepharospasm Botulinum toxin Cochrane review Evidence summary Evidence summary Involuntary Movements Other Patients Placebo Systematic review
Blindness
Blistering disease Blister Blister Dental medicine Dental medicine Disease Mouth Mouth Oral Blistering Diseases Otorhinolaryngology Otorhinolaryngology Pemphigus Pemphigus
Blister
Blocked duct
Blocked nose
Blockers of the renin-angiotensin system Trimethoprim or Trimethoprim-Sulfamethoxazole and Risk of Hyperkalaemia Among Patients Taking Renin-Angiotensin System Blockers Trimethoprim-Sulfamethoxazole and Risk of Sudden Death Among Patients Taking Renin-Angiotensin System Blockers
-Blocker
Block vertebra
Block
Blood-borne Hepatitis B Occupational Exposure to Blood and Body Secretions - Related Resources
Blood-borne infection Hepatitis B Occupational Exposure to Blood and Body Secretions Viral Hepatitis
003
011
021U
021
022